Martin Brook I, Levenson Linda M, Hollingworth William, Kliot Michel, Heagerty Patrick J, Turner Judith A, Jarvik Jeffrey G
Department of Medicine, Division of General Internal Medicine, Multidisciplinary Clinical Research Center, Box 359736, 325 Ninth Ave. Seattle, Washington 98104, USA.
BMC Musculoskelet Disord. 2005 Jan 18;6:2. doi: 10.1186/1471-2474-6-2.
Conservative treatment remains the standard of care for treating mild to moderate carpal tunnel syndrome despite a small number of well-controlled studies and limited objective evidence to support current treatment options. There is an increasing interest in the usefulness of wrist magnetic resonance imaging could play in predicting who will benefit for various treatments.
Two hundred patients with mild to moderate symptoms will be recruited over 3 1/2 years from neurological surgery, primary care, electrodiagnostic clinics. We will exclude patients with clinical or electrodiagnostic evidence of denervation or thenar muscle atrophy. We will randomly assign patients to either a well-defined conservative care protocol or surgery. The conservative care treatment will include visits with a hand therapist, exercises, a self-care booklet, work modification/ activity restriction, B6 therapy, ultrasound and possible steroid injections. The surgical care would be left up to the surgeon (endoscopic vs. open) with usual and customary follow-up. All patients will receive a wrist MRI at baseline. Patients will be contacted at 3, 6, 9 and 12 months after randomization to complete the Carpal Tunnel Syndrome Assessment Questionnaire (CTSAQ). In addition, we will compare disability (activity and work days lost) and general well being as measured by the SF-36 version II. We will control for demographics and use psychological measures (SCL-90 somatization and depression scales) as well as EDS and MRI predictors of outcomes.
We have designed a randomized controlled trial which will assess the effectiveness of surgery for patients with mild to moderate carpal tunnel syndrome. An important secondary goal is to study the ability of MRI to predict patient outcomes.
尽管有少量严格控制的研究且支持当前治疗方案的客观证据有限,但保守治疗仍是治疗轻至中度腕管综合征的标准治疗方法。人们越来越关注手腕磁共振成像在预测哪些患者将从各种治疗中获益方面可能发挥的作用。
在3年半的时间里,我们将从神经外科、初级保健、电诊断诊所招募200名有轻至中度症状的患者。我们将排除有去神经支配或大鱼际肌萎缩的临床或电诊断证据的患者。我们将把患者随机分配到明确的保守治疗方案或手术治疗组。保守治疗将包括接受手部治疗师的诊治、进行锻炼、发放一本自我护理手册、调整工作/限制活动、维生素B6治疗、超声治疗以及可能的类固醇注射。手术治疗将由外科医生决定(内镜手术与开放手术)并进行常规的后续随访。所有患者在基线时都将接受手腕磁共振成像检查。在随机分组后的3个月、6个月、9个月和12个月,我们将联系患者以完成腕管综合征评估问卷(CTSAQ)。此外,我们将比较由SF-36第二版测量的残疾情况(活动和工作天数损失)以及总体健康状况。我们将控制人口统计学因素,并使用心理测量指标(SCL-90躯体化和抑郁量表)以及结局的EDS和磁共振成像预测指标。
我们设计了一项随机对照试验,该试验将评估手术治疗轻至中度腕管综合征患者的有效性。一个重要的次要目标是研究磁共振成像预测患者结局的能力。